![]() |
|
|
2
*
Department of Food Science and Human Nutrition, Iowa State University, Ames, IA 50011;
Cancer Research Center of Hawaii, University of Hawaii, Honolulu, HI 96813; and
**
John A. Burns School of Medicine, University of Hawaii, Honolulu, HI 96822
2To whom correspondence should be addressed.
| ABSTRACT |
|---|
|
|
|---|
KEY WORDS: polyamines soy proteins biomarker colorectal cancer rats
| INTRODUCTION |
|---|
|
|
|---|
Polyamines are ubiquitous short-chain aliphatic amines that play an
important role in cellular proliferation and differentiation
(Heby 1991
, Morgan 1998
). Cellular levels
of polyamines increase significantly when cells are stimulated to
proliferate. Abnormal hyperproliferative cells such as preneoplastic
tissue exhibit a very high requirement for polyamines to sustain cell
growth through elevated DNA, RNA and protein synthesis (Pegg 1988
). Elevated polyamine levels have thus been found within
neoplastic tissues as well as within the flat colonic mucosa of
individuals at increased risk for neoplasia (Kingsnorth et al. 1984
, Wang et al. 1996
). Furthermore, the
polyamine biosynthetic enzymes, ornithine decarboxylase
(ODC)3
and S-adenosylmethionine decarboxylase (SAMDC), are highly
regulated in all of the cells and respond to a wide variety of
growth-promoting stimuli. A link between polyamine metabolism and
colorectal cancer risk seems well established in view of the reported
association between colorectal mucosal ODC activity and cancer risk
(Koo et al. 1988
, Luk and Baylin 1984
,
McCann et al. 1992
, McGarrity et al. 1990
, Narisawa et al. 1989
), and because
polyamine biosynthesis inhibition by ODC and/or SAMDC inhibitors is
protective against colorectal carcinogenesis in animal models
(Li et al. 1999
, Loser et al. 1997
,
Pegg et al. 1998
, Verma 1989
) and in
on-going human clinical chemopreventive trials (Meyskens and Gerner 1999
).
Epidemiologic, animal and clinical studies have shown that dietary
factors can be implicated in the etiology of colorectal cancer
(Shike 1999
). There is substantial evidence from studies
in laboratory rodents that a diet high in fiber can retard
carcinogenesis, but a diet high in saturated fat can promote tumor
growth. Soy proteins have also been shown to inhibit the growth of
various tumors including colon carcinogenesis in animal models
(Hawrylewicz et al. 1995
, Messina and Barnes 1991
, Thiagarajan et al. 1998
). It is believed
that this potential protection or promotion against colon cancer could
be associated with a modified cellular proliferation (Kim et al. 1998
, Lee et al. 1993
). Because mucosal
polyamine measurements have been shown to reflect cellular
proliferation, it can therefore be hypothesized that altered food
contents in diets and modified mucosal proliferation will correspond to
changes in mucosal polyamine measurements.
To validate mucosal polyamine analyses as a quantitative biomarker of dietary risk factors experimentally, the distribution of mucosal polyamines was determined along the intestinal tracts and the response of mucosal polyamines to certain dietary healthy or unhealthy factors was measured by using an in vivo animal model. In addition, the plausible mechanisms by which soy protein reduces mucosal polyamine levels were investigated.
| MATERIALS AND METHODS |
|---|
|
|
|---|
Male Wistar rats (n = 90), 56 wk of age, weighing 161203 g (Sasco, St. Louis, MO) were housed individually in raised stainless steel cages with wire-mesh floors and fronts under controlled conditions of light (12-h light:dark cycle), humidity (50 ± 15%) and temperature (22 ± 2°C). Water and food were consumed ad libitum. Body weight and water and food consumption were monitored weekly throughout both experiments.
Experimental diets.
A purified diet according to the formula given by Meyer et al. (1982)
was used as a basal diet. In the fiber and fat diets,
the carbohydrate pool was replaced partially by either 20% fiber
(freeze-dried table beets, Beta vulgaris L.) or 20%
lard (full refined lard; U.S. Biochemical, Cleveland, OH). In the soy
protein diet, the expense of casein was completely replaced by 20% soy
protein isolate. Soy protein isolate was prepared from dehulled and
defatted soybeans by removal of most of the nonprotein components,
containing about 90% protein on a moisture-free basis (Protein
Technologies International, St. Louis, MO). The contents of isoflavones
in these diets were measured by using our established HPLC method
(Wang et al. 1994
). The aglycone concentrations of
genistein, daidzein and glycitein in the 20% soy protein diet were
164.2, 114.6 and 20.8 µg/g, respectively. The amount
of isoflavones was not detectable in the basal, fiber and lard diets.
The other two of the six diets used in this study contained either
0.1% isoflavones (genistein:daidzein , 1:1, ICN, Costa Mesa, CA) in
the basal diet or 0.3% DL-methionine (ICN) in the 20% soy
protein diet. The composition of these six diets is summarized in
Table 1
. Diets were pelleted, dried and then stored at 4°C for not >1 mo.
|
After 1 wk acclimation to the basal diet, rats were randomly assigned into different diet groups. Two experiments were conducted. Experiment 1 included four diet groups as follows: 1) basal diet (n = 10); 2) 20% fiber diet (n = 9); 3) 20% lard diet (n = 10); and 4) 20% soy protein diet (n = 15). Experiment 2 involved four diet groups as follows: 1) basal diet (n = 8); 2) 0.1% soy isoflavone in basal diet (n = 15); 3) 20% soy protein diet (n = 8); and 4) 0.3% DL-methionine in 20% soy protein diet (n = 15). Rats were killed while under ethyl ether anesthesia after 2 wk of consuming the experimental diets in Experiment 1 or 4 wk in Experiment 2. The entire intestine was removed for mucosal samples. The protocols were approved by the University Animal Care and Use Committee.
Intestinal mucosa sample.
The entire intestine was excised and placed immediately into ice-cold 10 mmol/L PBS, pH 7.4. The whole intestine was then divided into seven segments, representing duodenum, jejunum, ileum, cecum, proximal colon, distal colon and rectum. Each segment was slit open and washed completely with chilled PBS. Duplicate mucosal samples were gently scraped off with a microscope slide from each segment and stored at -70°C until polyamine analysis.
Polyamine assay.
Each mucosal sample was suspended in ice-cold PBS and homogenized
on ice using a Polytron Homogenizer (Brinkman Instruments,, Westbury,
NY). After removal of gross debris by centrifugation, protein content
of the supernatant was measured by a Bio-Rad Protein Assay Kit
(Bio-Rad Laboratories, Richmond, CA). Diaminododecane (Dad) was added
as an internal standard, and then proteins were precipitated with a
final 0.5 mol/L perchloric acid. The protein-free supernatant (500
µL) was admixed with 350 µL saturated
sodium carbonate and 400 µL of 37 mmol/L dansyl
chloride; then the mixtures were incubated at 60°C for 1 h.
Dansylated polyamines were extracted in toluene, dried, then
redissolved in 100 µL of acetonitrile and finally
quantified with the use of our established HPLC method (Higuchi and Wang 1995
). Briefly, a reverse-phase chromatography
procedure using a Perkin-Elmer Peco-sphere 3 x 3 CR
C18, 33 x 4.6 mm i.d. cartridge column with 10 mmol/L
heptanesulfonate buffer, pH 3.4, in acetonitrile gradient at a flow
rate of 2.5 mL/min was applied. Dansylated polyamines were detected
using fluorescence detection set for excitation at 330 nm and emission
at 470 nm, and the peak areas indexed to an internal standard peak area
were used to calculate the values of mucosal polyamine levels. Results
of this HPLC have been found to be highly reproducible, i.e., the CV of
replicate measurements within a single batched assay or assayed
separately on different days was consistently <6%. With the use of
this method, the limit of detection is ~0.2 nmol/mg protein for
acetyl spermidine (AcSpd), cadaverine (Cad), putrescine (Put), acetyl
spermine (AcSpm), spermidine (Spd) or spermine (Spm).
Statistical analysis.
The SAS statistical system 6.12 (SAS Institute, Cary, NC) was used for
statistical analysis. For polyamine levels, the significance of
differences between diet groups was determined by one-way ANOVA and
comparisons between diet groups were analyzed by Tukeys post-hoc
test. Correlations between the rectal mucosal polyamine levels and
weekly energy intakes were computed by Pearsons correlation
coefficients, using mean values of each diet group as a partial
correlation between groups. Analyses of diet treatment with individual
energy intake for each animal as a covariant were performed by the
General Linear Models procedure of SAS. Data are presented as means
± SD. Differences were considered significant at
P
0.05.
| RESULTS |
|---|
|
|
|---|
|
|
|
Significant linear correlations were observed between average rectal
polyamine levels and weekly energy intakes in these four diet groups
(r = 0.9720.991, P < 0.01;
Fig. 2
). In addition, analyses of diet treatment with individual energy
intakes for each rat as a covariant showed that these significant
correlations still existed after adjustment for energy intake
(P < 0.05), suggesting an association of mucosal
polyamine levels with dietary variables other than energy intakes.
|
| DISCUSSION |
|---|
|
|
|---|
In this study, we first measured the mucosal polyamine distribution
along intestinal tracts in rats fed a normal basal diet and found a
high level of mucosal polyamines in the duodenum, jejunum and ileum and
a low level in the cecum, colon and rectum. This distributive profile
of intestinal polyamine levels parallels the established pattern of
cellular proliferation in the normal intestine, which decreases from
duodenum to colon (Dowling 1982
). This is also
consistent with a previous study by Hosomi et al. (1986)
who reported a similar distribution of mucosal polyamines as measured
by a semiquantitative method.
We then evaluated the response of mucosal polyamines to certain dietary risk factors including fat, fiber and soy proteins. Relative to rats fed the basal diet, we observed the following: 1) mucosal polyamine levels in the large intestine were increased significantly in response to the 20% lard fat diet; 2) mucosal polyamine levels in the small bowel were decreased significantly in response to the 20% beet fiber diet; 3) mucosal polyamine levels in both large and small intestines were decreased significantly in response to the 20% soy protein diet. These corresponding changes of mucosal polyamine levels to dietary high or low risk factors may thus support a value of mucosal polyamine analysis as an intermediate index of colorectal cancer risk in dietary intervention studies. However, additional studies that include different diets and different types of nutrients are warranted to support this conclusion.
Finally, we addressed the mechanisms of polyamine levels regulated by
dietary factors, especially by a soy protein diet. The significant
linear correlation observed between rectal polyamine levels and dietary
energy intakes in four different diet groups indicates a contributory
effect of dietary energy consumption on mucosal polyamine levels.
Although the detailed mechanism is not clear, the correlation of energy
intake with mucosal polyamine levels is not unexpected. An increase in
energy intake in rodents has been shown consistently to be associated
with elevated rates of growth and metabolism, and a decrease of energy
intake (energy restriction) has been demonstrated repeatedly to extend
life span and inhibit spontaneous and chemically induced neoplasia
(Birt et al. 1991
, Leakey et al. 1998
).
Moreover, cancer prevention by energy restriction has been suggested to
be mediated mainly through reduction of cellular proliferation
(Fischer and Lutz 1998
). Therefore, the strong
correlation between rectal mucosal polyamine levels and energy intakes
demonstrated in this study may indicate an energy-reduced mechanism
for a high soy protein diet in cancer prevention.
In addition, subsequent analyses of diet treatment with individual
energy intakes for each rat as a covariant showed that a significant
correlation between diet groups and rectal mucosa polyamine levels
still existed after adjustment for energy intake (P < 0.05). That may indicate an association of mucosal polyamine levels
with other dietary variables such as diet composition. The inhibitory
effect of soy protein on carcinogenesis in animal models has been
attributed to the presence of certain anticarcinogenic phytochemicals
such as phytoestrogenic isoflavones (genistein and daidzein). Genistein
and daidzein have been shown to exhibit a number of chemopreventive
characteristics that may be associated with cancer prevention
(Adlercreutz 1995
). The total isoflavone aglycones in
the 20% soy protein diet were ~0.03%. Supplementation of soy
isoflavones up to 0.1% in the basal diet, however, did not
significantly affect mucosal polyamine measurements. This negative
result of isoflavones on colonic cellular proliferation appears to be
in agreement with studies conducted in other laboratories.
Davies et al. (1999)
reported that soy isoflavones had
no inhibitory effect on the frequency of colonic tumors and
Srensen et al. (1998)
found that dietary soy isoflavones
did not affect intestinal tumor development in APC-mutated Min
mice. On the contrary, Rao et al. (1997)
found that
genistein at 250 µg/g diet enhanced
azoxymethane-induced colon carcinogenesis in an animal model.
Another possible mechanism by which soy protein products inhibit
tumorigenesis may be related to the deficiency of methionine
(Hawrylewicz et al. 1995
). The concentration of
methionine in soy protein is much less than that found in casein, ~13
g/kg compared with 26 g/kg. Methionine plays a critical role in cell
development because it is the precursor of S-adenosylmethine, which
is the primary methyl-group donor in a large variety of methylation
reactions (Cooper 1983
). In addition, methionine is the
precursor of the aminopropyl moieties of spermidine and spermine
(Pegg 1988
). It is likely that methionine could regulate
cellular levels of polyamines. Although several reports have suggested
that methionine and/or methionine-related metabolites might reduce
the incidence of colorectal cancer (Cooper 1983
,
Giovannucci et al. 1995
), a recent study showed that a
diet supplemented with methionine enhanced polyamine biosynthesis and
hastened the appearance of intestinal preneoplastic changes and
tumorigenesis (Duranton et al. 1999
). However, we did
not find that supplementation of 0.3% DL-methionine in the
20% soy protein diet significantly restored mucosal polyamine levels
in comparison with soy protein diet alone (P < 0.06).
In conclusion, we have demonstrated for the first time that mucosal polyamine levels are altered by dietary interventions. Because the index of mucosal polyamine measurements represents colonic cancer risk, our data may offer insight into a mechanism by which dietary factors modify the risk of colorectal cancer. Consumption of soy protein could suppress mucosal polyamine levels, at least in part, through a dietary energy reduction mechanism. Further studies are warranted to support the usefulness of quantitative polyamine analysis in intestinal mucosa as an intermediate biomarker for dietary factors in experimental studies.
| ACKNOWLEDGMENTS |
|---|
| FOOTNOTES |
|---|
3 Abbreviations used: AcSpd, acetyl spermidine;
AcSpm, acetyl spermine; Cad, cadaverine; Dad, diaminododecane; ODC,
ornithine decarboxylase; Put, putrescine; SAMDC,
S-adenosylmethionine decarboxylase; Spd, spermidine; Spm,
spermine. ![]()
Manuscript received September 23, 1999. Initial review completed November 15, 1999. Revision accepted March 15, 2000.
| REFERENCES |
|---|
|
|
|---|
1. Adlercreutz H. Phytoestrogens: epidemiology and a possible role in cancer protection. Environ. Health Perspect. 1995;103(suppl. 7):103-112
2. American Institute of Nutrition Report of the American Institute of Nutrition ad hoc committee on standards for nutritional studies. J. Nutr. 1977;107:1340-1348
3. American Institute of Nutrition Second report of the ad hoc committee on standards for nutritional studies. J. Nutr. 1980;110:1726
4.
Birt D. F., Pelling J. C., White L. T., Dimitroff K., Barnett T. Influence of diet and caloric restriction on the initiation and promotion of skin carcinogenesis in the Sencar mouse model. Cancer Res 1991;51:1851-1854
5. Cooper A.J.L. Biochemistry of sulfur-containing amino acids. Annu. Rev. Biochem. 1983;52:187-222[Medline]
6.
Davies M. J., Bowey E. A., Adlercreutz H., Rowland I. R., Rumsby P. C. Effects of soy or rye supplementation of high-fat diets on colon tumor development in azoxymethane-treated rats. Carcinogenesis 1999;20:927-931
7. Dowling R. H. Small bowel adaptation and its regulation. Scand. J. Gastroenterol. Suppl. 1982;74:53-74[Medline]
8.
Duranton B., Freund J. N., Galluser M., Schleiffer R., Gosse F., Bergmann C., Hasselmann M., Raul F. Promotion of intestinal carcinogenesis by dietary methionine. Carcinogenesis 1999;20:493-497
9. Fischer W. H., Lutz W. K. Influence of diet restriction and tumor promoter dose on cell proliferation, oxidative DNA damage and rate of papilloma appearance in the mouse skin after initiation with DMBA and promotion with TPA. Toxicol. Lett. 1998;98:59-69[Medline]
10.
Giovannucci E., Rimm E. B., Ascherio A., Stampfer M. J., Colditz G. A., Willett W. C. Alcohol, low-methionine low-folate diets and risk of colon cancer in men. J. Natl. Cancer Inst. 1995;87:265-273
11. Hawrylewicz E. J., Zapata J. J., Blair W. H. Soy and experimental cancer: animal studies. J. Nutr. 1995;125(suppl.):698S-708S
12. Heby O. Role of polyamines in cell growth and differentiation. Differentiation 1991;19:1-20
13. Higuchi C. M., Wang W. Comodulation of cellular polyamines and proliferation: biomarker application to colorectal mucosa. J. Cell. Biochem. 1995;57:256-261[Medline]
14. Hosomi M., Smith S. M., Murphy G. M., Dowling R. H. Polyamine distribution in the rat intestinal mucosa. J. Chromatogr. 1986;375:267-275[Medline]
15. Kim D. Y., Chung K. H., Lee J. H. Stimulatory effects of high-fat diets on colon cell proliferation depend on the type of dietary fat and site of the colon. Nutr. Cancer 1998;30:118-123[Medline]
16. Kingsnorth A. N., Lumsden A. B., Wallace H. M. Polyamines in colorectal cancer. Br. J. Surg. 1984;71:791-794[Medline]
17. Koo H. B., Sigurdson E. R., Daly J. M., Berenson M., Groshen S., DeCosse J. J. Ornithine decarboxylase levels in the rectal mucosa of patients with colonic neoplasia. J. Surg. Oncol. 1988;38:240-243[Medline]
18. Leakey J. E., Seng J. E., Barnas C. R., Baker V. M., Hart R. W. A mechanistic basis for the beneficial effects of caloric restriction on longevity and disease: consequences for the interpretation of rodent toxicity studies. Int. J. Toxicol. 1998;17(suppl. 2):5-56
19. Lee D. Y., Chapkin R. S., Lupton J. R. Dietary fat and fiber modulate colonic cell proliferation in an interactive site specific manner. Nutr. Cancer 1993;20:107-118[Medline]
20.
Li H., Schut H.A.J., Conran P., Kramer P. M., Lubet R. A., Steele V. E., Hawk E. E., Kelloff G. J., Pereira M. A. Prevention by aspirin and its combination with D,L-
-difluoromethylornithine of azoxymethane-induced tumors, aberrant crypt foci and prostaglandin E2 levels in rat colon. Carcinogenesis 1999;20:425-430
21.
Lipkin M. Biomarkers of increased susceptibility to gastrointestinal cancer: new application to studies of cancer prevention in human subjects. Cancer Res 1988;48:235-245
22. Loser C., Fitting T., Folsch U. R. Importance of intracellular S-adenosylmethionine decarboxylase activity for the regulation of camostate-induced pancreatic polyamine metabolism and growth: in vivo effect of two novel S-adenosylmethionine decarboxylase inhibitors. Digestion 1997;58:258-265[Medline]
23. Luk G. D., Baylin S. B. Ornithine decarboxylase as a biologic marker in familial colonic polyposis. N. Engl. J. Med. 1984;311:80-83[Abstract]
24. McCann P. P., Bitoni A. J., Pegg A. E. Inhibition of polyamine metabolism and the consequent effects on cell proliferation. Wattenberg L. Lipkin M. Boone C. W. Kelloff G. J. eds. Cancer Chemoprevention 1992:531-539 CRC Press Boca Raton, FL.
25. McGarrity T. J., Peiffer L. P., Bartholomew M. J., Pegg A. E. Colonic polyamine content and ornithine decarboxylase activity as markers for adenomas. Cancer 1990;66:1539-1543[Medline]
26.
Messina M., Barnes S. The role of soy products in reducing risk of cancer. J. Natl. Cancer Inst. 1991;83:541-546
27.
Meyer O., Blom L., Sondergaard D. The influence of minerals and protein on the nephrocalconosis potential for rats on semisynthetic diets. Lab. Anim. 1982;16:271-273
28.
Meyskens F. L., Gerner E. W. Development of difluoromethylornithine (DFMO) as a chemoprevention agent. Clin. Cancer Res. 1999;5:945-951
29. Moore M. A., Tsuda H. Chronically elevated proliferation as a risk factor for neoplasia. Eur. J. Cancer Prev. 1998;7:353-385[Medline]
30. Morgan D. M. Polyamines. An introduction. Methods Mol. Biol. 1998;79:3-30[Medline]
31. Narisawa T., Takahashi M., Niwa M., Koyama H., Kotanagi H., Kusaka N., Yamazaki Y., Nagasawa O., Koyama H., Wakizaka A., Fukaura Y. Increased ornithine decarboxylase activity in large bowel with multiple tumors, adenocarcinoma, and adenoma. Cancer 1989;63:1572-1576[Medline]
32.
Pegg A. E. Polyamine metabolism and its importance in neoplastic growth and as a target for chemotherapy. Cancer Res 1988;48:759-774
33. Pegg A. E., Xiong H., Feith D. J., Shantz L. M. S-Adenosylmethionine decarboxylase: structure, function and regulation by polyamines. Biochem. Soc. Trans. 1998;26:580-586[Medline]
34.
Rao C. V., Wang C. X., Simi B., Lubet R., Kelloff G., Steele V., Reddy B. S. Enhancement of experimental colon cancer by genistein. Cancer Res 1997;57:3717-3722
35. Shike M. Diet and lifestyle in the prevention of colorectal cancer: an overview. Am. J. Med. 1999;106:11S-15S[Medline]
36. Srensen I. K., Kristiansen E., Mortensen A., Nicolaisen G. M., Wijnands J. A., van Kranen H. J., van Kreijl C. F. The effect of soy isoflavones on the development of intestinal neoplasia in ApcMin mouse. Cancer Lett 1998;130:217-225[Medline]
37. Thiagarajan D. G., Bennink M. R., Bourquin L. D., Kavas F. A. Prevention of precancerous colonic lesions in rats by soy flakes, soy flour, genistein, and calcium. Am. J. Clin. Nutr. 1998;68:1394S-1399S[Abstract]
38.
Verma A. K. The enzyme-activated irreversible inhibitor of ornithine decarboxylase, D,L-
-difluoromethylornithine: a chemopreventive agent. Prev. Med. 1989;18:646-652[Medline]
39. Wang W., Liu L. Q., Higuchi C. M. Mucosal polyamine measurements and colorectal cancer risk. J. Cell. Biochem. 1996;63:252-257[Medline]
40. Wang W., Vincent D. L., Early R. J., Weems C. W. The quantification of phytoestrogens in fresh plant materials by reversed-phase high performance liquid chromatography. Acta Bot. Yunnanica 1994;16:424-430
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||